Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 0.93 AUD 0.54% Market Closed
Market Cap: 188.7m AUD
Have any thoughts about
Imricor Medical Systems Inc?
Write Note

Imricor Medical Systems Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imricor Medical Systems Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Imricor Medical Systems Inc
ASX:IMR
Cash from Operating Activities
-$13m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.9B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.8B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
8%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.8B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

Imricor Medical Systems Inc
Glance View

Market Cap
188.7m AUD
Industry
Health Care

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The firm sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.

IMR Intrinsic Value
0.46 AUD
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Imricor Medical Systems Inc's Cash from Operating Activities?
Cash from Operating Activities
-13m USD

Based on the financial report for Dec 31, 2023, Imricor Medical Systems Inc's Cash from Operating Activities amounts to -13m USD.

What is Imricor Medical Systems Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-22%

Over the last year, the Cash from Operating Activities growth was 21%. The average annual Cash from Operating Activities growth rates for Imricor Medical Systems Inc have been -2% over the past three years , -22% over the past five years .

Back to Top